We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
+65.27%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$5.03B
AUM Growth
+$1.32B
Cap. Flow
-$125M
Cap. Flow %
-2.48%
Top 10 Hldgs %
53.64%
Holding
139
New
31
Increased
25
Reduced
19
Closed
25

Top Buys

Rank Stock Value
1
KRRO icon
Korro Bio
KRRO
+$47.2M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$34M
3
ANAB icon
AnaptysBio
ANAB
+$23.6M
4
QTNT
Quotient Limited Ordinary Shares
QTNT
+$20.7M
5
ZGNX
Zogenix, Inc.
ZGNX
+$20.4M

Top Sells

Rank Stock Value
1
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
+$104M
2
SLDB icon
Solid Biosciences
SLDB
+$69.8M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$46.8M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$36.4M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$33.9M

Sector Composition

Rank Sector Weight
1 Healthcare 95.17%
2 Financials 0.38%
3 Technology 0.12%
4 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNA
126
DELISTED
Allena Pharmaceuticals
ALNA
– –
-132,300
Closed -$521K
CORV
127
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
– –
-1,000,000
Closed -$2M
RARX
128
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-14,455
Closed -$342K
MDCO
129
DELISTED
Medicines Co
MDCO
– –
-19,532
Closed -$977K
ABEOW
130
DELISTED
Abeona Therapeutics Inc Warrant
ABEOW
– –
-659,636
Closed -$145K
HSACU
131
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
– –
-400,000
Closed -$4.29M
ONCE
132
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-350,000
Closed -$33.9M
DOVA
133
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
– –
-3,708,705
Closed -$104M
2 3 4 5
6

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Perceptive Advisors held 139 positions worth $5.03B, up 36% from $3.71B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Perceptive Advisors's Q4 2019 filing shows 31 new, 25 increased, 19 reduced and 25 closed positions. Its largest new stake was Korro Bio: 60,686 shares worth $49.8M. The largest sale was Dova Pharmaceuticals, Inc. Common Stock, an estimated $104M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier, followed by Financials and Technology.

  • Perceptive Advisors's largest Q4 2019 buy was Korro Bio: 60,686 shares worth $49.8M.
  • Perceptive Advisors added most to Quotient Limited Ordinary Shares in Q4 2019, an estimated $20.7M increase.
  • Perceptive Advisors's biggest Q4 2019 reduction was Neurocrine Biosciences, cutting an estimated $46.8M.
  • Perceptive Advisors fully exited Dova Pharmaceuticals, Inc. Common Stock in Q4 2019, selling an estimated $104M.
  • Perceptive Advisors's ten largest holdings make up 54% of its $5.03B portfolio in Q4 2019.
  • Perceptive Advisors opened 31 new positions and closed 25 in Q4 2019.
  • Perceptive Advisors's portfolio value rose 36% quarter-over-quarter to $5.03B.

Based on Perceptive Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.